معرفی
Karin Hansson is a Postdoctoral Fellow and Associate Researcher at Lund University Cancer Centre (LUCC) within the Division of Translational Cancer Research at Lund University's Faculty of Medicine. Her work primarily focuses on cancer research with special emphasis on neuroblastoma and breast cancer.
Her research interests span multiple areas of oncology including tumor evolution, chemoresistance mechanisms, and molecular pathways in cancer development. Dr. Hansson's work particularly examines neuroblastoma treatment resistance patterns, tumor initiating cells in breast cancer, and molecular function of cancer progression. The research has significant implications for developing more effective cancer therapies targeting treatment-resistant cancers.
Her publication record shows a consistent focus on cancer model systems, with recent work analyzing evolutionary patterns in cancer under chemotherapy, USP7 protein's role in cancer development, and clinically relevant treatment approaches using patient-derived xenograft models. These studies demonstrate her expertise in both experimental oncology and translational research bridging laboratory findings to clinical applications.
Dr. Hansson has secured significant research funding as Principal Investigator for the project 'Elucidating the molecular function of tumour initiating cells in breast cancer progression and treatment resistance' funded by Cancerfonden (2025-2028). She also serves as Research Student in the long-term project 'Deciphering and targeting treatment resistant metastatic neuroblastoma' supported by multiple funding bodies including Cancerfonden, Swedish Research Council, The Royal Physiographic Society in Lund, and The Swedish Childhood Cancer Fund.
She actively contributes to academic discourse through seminar presentations, having participated in both the LUCC Breast Cancer Seminar (2025) and the LUCC Child Neuroblastoma Seminar (2021), demonstrating her commitment to knowledge sharing within the cancer research community.
